LAUSANNE, Switzerland--(BUSINESS WIRE)--ADC Therapeutics SA (NYSE: ADCT) today announced that it has completed a series of strategic transactions in which it: Entered into a new $175 million senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results